✦ LIBER ✦

PMD31 Cost-Effectiveness Analysis of EGFR Testing and Gefitinib for Non-Small-Cell Lung Cancer (NSCLC) in Japan

✍ Scribed by T. Shiroiwa; Y. Miyoshi; K. Tsutani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-009 Differential effects of gefitinib

✍ Mukohara, T.; Engelman, J.; Lindeman, N.; Pearlberg, J.; Cantley, L.; Johnson, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGF

✍ O Arrieta; P Anaya; RJ López; AC Polanco 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PCN100 COST-EFFECTIVENESS OF GEFITINIB V

✍ J Jacob; M Henriksson; D Brattström 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

P17 EGFR, K-RAS and HER2 mutations as pr

✍ A. Voutsina; A. Kalikaki; Y. Ampatziadis-Michailidis; J. Souglakos; A. Koytsopoy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERL

✍ TE Ciuleanu; M Dediu; LN Minea; S Baculea; M Szkultecka-Debek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN34 COST-EFFECTIVENESS OF GEFITINIB FO

✍ PH Liu; FC Hu; JD Wang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB